Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Corticosteroid-responsive dermatoses Age: Adult |
Dose: Cream – 0.05% Frequency: once or twice daily Duration: maximum four weeks Note: Apply thinly on affected areas. Continuous daily treatment for longer than four weeks is not recommended. If the condition worsens or does not improve within four weeks, treatment and diagnosis should be re-evaluated. |
|
Indication: Corticosteroid-responsive dermatoses Age: Adult |
Dose: Ointment – 0.05% Frequency: once or twice daily Duration: maximum four weeks Note: Apply thinly on affected areas. Continuous daily treatment for longer than four weeks is not recommended. If the condition worsens or does not improve within four weeks, treatment and diagnosis should be re-evaluated. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Corticosteroid-responsive dermatoses Age: Children 12 years and over |
Dose: 0.05% cream or ointment Frequency: once or twice daily Note: Applied thinly on affected areas. When clobetasone is used in the treatment of dermatoses in children, extreme caution is required and treatment should not normally exceed 7 days. If the condition worsens or does not improve within 7 days, treatment should be reviewed. Once the condition has been controlled, the frequency of application should be reduced to the lowest effective dose for the shortest time possible. |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Application – Minimum quantity Duration: Shortest duration Note: In case of systemic absorption (when application is over a large surface area for a prolonged period) metabolism and elimination may be delayed therefore increasing the risk of systemic toxicity. Minimum quantity should be used for the shortest duration to achieve the desired clinical benefit. |
Administration
- Clean affected area
- Apply thin layer
Side Effect
- Local atrophic changes
- pigmentation changes & hypertrichosis
- Increased liability to infection
- Infections may be masked
- Acute adrenal insufficiency
- Growth retardation in child
- Cushingoid symptoms
- Amenorrhoea
- hyperhidrosis
- skin thinning
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Presence Of Acute Infections
|
Can mask and worsen infections
|
|
Treatment Of Rosacea
|
Can worsen condition
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, protected from light and moisture. Do not freeze. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.